Fluorinov Pharma Overview
- Year Founded
-
2008
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$31.7M
Fluorinov Pharma General Information
Description
Operator of a pharmaceutical company intended to develop fluorine-based novel, safer and more effective medicine. The company's services include developing small molecule product portfolio for Multiple Myeloma, Waldenström's Macroglobulinemia, Leukemia, Glioblastoma, Lung and Pancreatic Cancers and Central Nervous System disorders, enabling patients to avail therapeutics to treat and avoid cancer diseases.
Contact Information
Website
www.fluorinovpharma.comCorporate Office
- 101 College Street, MaRS Centre, South Tower
- Suite 300, L-349
- Toronto, Ontario M5G 1L7
- Canada
Corporate Office
- 101 College Street, MaRS Centre, South Tower
- Suite 300, L-349
- Toronto, Ontario M5G 1L7
- Canada
Fluorinov Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 27-Jan-2016 | $31.7M | Completed | Generating Revenue | ||
| 4. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 3. Early Stage VC | 07-Jan-2015 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 07-Jun-2012 | $1.47M | $1.47M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2010 | Completed | Generating Revenue |
Fluorinov Pharma Comparisons
Industry
Financing
Details
Fluorinov Pharma Competitors (27)
One of Fluorinov Pharma’s 27 competitors is Intas Pharmaceuticals, a Private Equity-Backed company based in Ahmedabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
| Biocon Biologics | Formerly PE-Backed | Bengaluru, India | ||||
| Gesynta Pharma | Venture Capital-Backed | Stockholm, Sweden | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA |
Fluorinov Pharma Patents
Fluorinov Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20190016689-A1 | Novel fluorinated quinazoline derivatives as egfr inhibitors | Inactive | 06-Jan-2016 | ||
| CA-2881986-A1 | Fluorinated epoxyketone-based tetrapeptide compounds and uses thereof as proteasome inhibitors | Inactive | 21-Aug-2012 |
Fluorinov Pharma Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FACIT | Venture Capital | Minority | ||
| Ontario Brain Institute | Accelerator/Incubator | |||
| Ontario Institute for Cancer Research | Not-For-Profit Venture Capital | Minority |
Fluorinov Pharma FAQs
-
When was Fluorinov Pharma founded?
Fluorinov Pharma was founded in 2008.
-
Where is Fluorinov Pharma headquartered?
Fluorinov Pharma is headquartered in Toronto, Canada.
-
What industry is Fluorinov Pharma in?
Fluorinov Pharma’s primary industry is Drug Discovery.
-
Is Fluorinov Pharma a private or public company?
Fluorinov Pharma is a Private company.
-
What is the current valuation of Fluorinov Pharma?
The current valuation of Fluorinov Pharma is .
-
What is Fluorinov Pharma’s current revenue?
The current revenue for Fluorinov Pharma is .
-
How much funding has Fluorinov Pharma raised over time?
Fluorinov Pharma has raised $1.47M.
-
Who are Fluorinov Pharma’s investors?
FACIT, Ontario Brain Institute, and Ontario Institute for Cancer Research have invested in Fluorinov Pharma.
-
Who are Fluorinov Pharma’s competitors?
Intas Pharmaceuticals, Biocon Biologics, Gesynta Pharma, Ability Pharma, and Genentech are some of the 27 competitors of Fluorinov Pharma.
-
When was Fluorinov Pharma acquired?
Fluorinov Pharma was acquired on 27-Jan-2016.
-
Who acquired Fluorinov Pharma?
Fluorinov Pharma was acquired by Trillium Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process